Acasti Pharma, Inc. - Class A Common Stock [ACST]
$1.05 0.04 (3.96%)
Market Cap 80 Million
Acasti Pharma Inc is a biopharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. The key product candidate of the company, CaPre is developed for the treatment of severe hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. The company operates through the single segment being Development and commercialization of prescription drugs.
EPS -0.07 P/E Ratio 0.00
Previous Earnings Thu, Feb 14, 2019
Latest Earnings Wed, Jun 26, 2019 Today
Pay Date --
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.